Rasagiline Tablets (Rasagiline Mesylate)

Adult dose

Administer orally once daily to adults as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended starting dose for patients taking levodopa is 0.5mg once daily. If well tolerated but an adequate clinical response is not achieved, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This drug should not be used by individuals who are allergic to the active ingredients or other components of this drug. It should also not be taken with other MAO inhibitors or specific analgesics, cough medicines, etc., or if usage was stopped within 2 weeks. It is unsafe to administer this drug to patients with moderate or severe liver dysfunction. Various side effects such as flu, skin cancer, leukopenia, allergies, headaches, dizziness, nausea, and insomnia may occur during the use of this drug. Particularly in patients with Parkinson's disease, symptoms such as hallucinations, confusion, and movement disorders may arise, requiring caution. This drug can cause fluctuations in blood pressure or hypotension, so blood pressure should be regularly monitored. Impulse control disorders may occur, so patients and caregivers should vigilantly observe for symptoms such as obsessive behavior or pathological gambling. Patients with decreased liver or kidney function should consult a doctor before taking this medication, and patients with severe liver disease should avoid it. This drug may induce drowsiness or sudden sleep, so caution is necessary when driving or operating hazardous machinery. There are numerous drug interactions, so consultation with a doctor or pharmacist is essential when taking it with antidepressants, analgesics, cold medicines, etc. If pregnant or nursing, a thorough consultation with a specialist should be conducted before use. Serious side effects may occur in cases of overdose, so it is imperative to adhere to the prescribed method and dosage. The safety of this drug in children has not been established; therefore, it is advisable not to use it in individuals under 18 years of age. When storing, keep it in a cool place out of reach of children and do not transfer it to another container.

• Influenza
• skin cancer
• leukopenia
• allergies
• loss of appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. Additionally, it is best to store the drug at room temperature between 1°C and 25°C, avoiding excessively hot or cold places.

Appearance

White or nearly white, flat round tablets with edges

Package unit

For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle